期刊文献+

温阳化瘀法对体外培养的内异症内膜细胞VEGF分泌的影响

Influence of Wenyang Huayu Method on VEGF Secretion in Endometrial Cells of Patients with Endometriosis Cultured in Vitro
下载PDF
导出
摘要 目的:观察温阳化瘀法对体外培养的子宫内膜异位症患者在位、异位内膜细胞血管内皮生长因子(VEGF)分泌的干预作用。方法:将成功体外培养的15例内异症患者在位、异位内膜细胞(实验组)及10例非内异症患者在位内膜细胞(对照组)进行分组,实验组随机分为5组,即温阳化瘀法高、中、低剂量组、孕三烯酮组、空白对照组。采用酶联免疫吸附试验(ELISA)法检测各组上清液中VEGF的水平。结果:体外培养的子宫内膜异位症异位、在位内膜细胞上清液中VEGF水平较非内异症的高,采用温阳化瘀法干预后可以降低VEGF水平(P<0.05)。结论:子宫内膜异位症发生与VEGF表达失调有关,温阳化瘀法可以降低VEGF水平。 Objective:To observe the interventive effect of Wenyang Huayu method on VEGF secretion in eutopic endometrium and ectopic endometrium of patients with endometriosis cultured in vitro.Methods:The eutopic endometrium and ectopic endometrium of 15 patients with endometriosis and the eutopic endometrium of 10 non endometrium controls were cultured in vitro and then were randomly divided into six groups:the high dosage group with Wenyang Huayu method,the medium one and the low one,Gestrinong group,normal control group,and non endometrium control group.VEGF level in the supernatant in each group was detected with ELISA.Results:VEGF level in the supernatant of eutopic endometrium and ectopic endometrium of patients with endometriosis cultured in vitro went up.Wenyang Huayu drug could reduce the expression of VEGF.Conclusion:The occurrence of endometriosis is associated with abnormal expression of VEGF.Wenyang Huayu drug can result in down-regulation of VEGF.
出处 《中医药信息》 2013年第5期28-31,共4页 Information on Traditional Chinese Medicine
关键词 子宫内膜异位症 VEGF 温阳化瘀法 Endometriosis VEGF Wenyang Huayu method
  • 相关文献

参考文献15

  • 1Wu MY, Ho HN. The role of cytokines in endometriosis [ J ]. Am J Re- prod Immuno1,2003,49 (5) :285 - 296.
  • 2黄艳辉,梁雪芳,司徒仪.浅谈温阳法在子宫内膜异位症中的应用[J].河北中医,2009,31(4):625-627. 被引量:9
  • 3马小娜,任国辉,闫军堂,刘晓倩,王庆国.子宫内膜异位症的中医辨治思路与方法[J].中医药学报,2011,39(5):50-52. 被引量:3
  • 4马小娜,闫军堂,任国辉,刘晓倩,王庆国.子宫内膜异位症中医病因病机的认识探讨[J].中医药学报,2012,40(3):63-66. 被引量:31
  • 5秦莉花,秦明春,李晟,王若光,刘小丽,李春梅,吴长虹.人子宫内膜细胞原代体外培养方法[J].湖南中医药大学学报,2007,27(3):8-10. 被引量:13
  • 6Cho SH, Oh Y J, 5/am A, et al. Evaluation of serum and urinary angio-genic factom in patients with endometriosis [ J ]. Am J Reprod 1mmu- nol,2007,53 (6) :497 -504.
  • 7Pupo - Nogueira A, de Oliveira RM, Petta CA, et al. Vascular Endo- thelial Growth Factor concentrations in the serum and peritoneal fluid of women with endometriosis [ J ]. Int J Gynecol Obstet,2007,99 ( 1 ) : 33 - 37.
  • 8Maehado DE, Abro MS, Berardo PT, et al. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its re- ceptor VEGFR - 2 ( Flk - 1 ) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum [ J ]. Fertil Ster- i1,2008,90( 1 ) : 148 - 155.
  • 9Gareia - Manem M, Alcazar JL, Toledo G. Vascular endothelial growth factor(VEGF) and ovarian endometriosis: correlation between VEGF serum levels, VEGF cellular expression, and pelvic pain [ J ]. Fertil Steril,2007,88(2) :513 -515.
  • 10Olive DL, Lindheim SR, Pritts EA. New medical treatments for endo-metriosis [ J ]. Beat Pract Res Clin 0bstet Gynaecol, 2004,18 ( 2 ) : 319 - 328.

二级参考文献26

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部